Literature DB >> 17374511

The role of mycoplasmas in pregnancy outcome.

David Taylor-Robinson1.   

Abstract

Mycoplasma hominis was isolated from a Bartholin's gland abscess 70 years ago, and ureaplasmas were isolated from the genital tract about 20 years later. Subsequently, reports incriminating mycoplasmas in the known adverse outcomes of pregnancy have been legion. Without doubt these genital mycoplasmas are able to invoke an inflammatory response and take part in the cascade of events that culminates in preterm birth. Their role in this and other conditions is becoming clearer, but controversy remains due mainly to investigators often ignoring bacterial vaginosis, with its complex of bacteria, and failing to disentangle their role from that of the genital mycoplasmas. This is a theme that will be highlighted in this chapter, in which an attempt is made to indicate what is indisputable (surprisingly little) and what is not, and where further research would be helpful.

Entities:  

Mesh:

Year:  2007        PMID: 17374511     DOI: 10.1016/j.bpobgyn.2007.01.011

Source DB:  PubMed          Journal:  Best Pract Res Clin Obstet Gynaecol        ISSN: 1521-6934            Impact factor:   5.237


  12 in total

1.  Role of Mycoplasma and ureaplasma species in female lower genital tract infections.

Authors:  Meghan Arvind Patel; Paul Nyirjesy
Journal:  Curr Infect Dis Rep       Date:  2010-11       Impact factor: 3.725

2.  Simultaneous identification of 14 genital microorganisms in urine by use of a multiplex PCR-based reverse line blot assay.

Authors:  Michelle L McKechnie; Richard Hillman; Deborah Couldwell; Fanrong Kong; Eleanor Freedman; Hui Wang; Gwendolyn L Gilbert
Journal:  J Clin Microbiol       Date:  2009-04-08       Impact factor: 5.948

3.  Epidemiology of Mycoplasma acquisition in male HIV-1 infected patients: a multistage cross-sectional survey in Jiangsu, China.

Authors:  L-S Chen; J-R Wu; B Wang; T Yang; R Yuan; Y-Y Zhao; J-S Xu; H-X Guo; X-P Huan
Journal:  Epidemiol Infect       Date:  2015-03-20       Impact factor: 4.434

4.  Comparison of the new Mycofast Revolution assay with a molecular assay for the detection of genital mycoplasmas from clinical specimens.

Authors:  Mathys J Redelinghuys; Marthie M Ehlers; Andries W Dreyer; Hennie A Lombaard; Marleen M Kock
Journal:  BMC Infect Dis       Date:  2013-09-30       Impact factor: 3.090

5.  Assessing the prevalence of mycoplasma contamination in cell culture via a survey of NCBI's RNA-seq archive.

Authors:  Anthony O Olarerin-George; John B Hogenesch
Journal:  Nucleic Acids Res       Date:  2015-02-24       Impact factor: 16.971

6.  Prevalence and Antibiotic Susceptibility of Mycoplasma hominis and Ureaplasma urealyticum in Pregnant Women.

Authors:  Min Young Lee; Myeong Hee Kim; Woo In Lee; So Young Kang; You La Jeon
Journal:  Yonsei Med J       Date:  2016-09       Impact factor: 2.759

7.  Identification of vaccine candidate proteins in Ureaplasma urealyticum causing infertility.

Authors:  Shilpa Jeevappa Shiragannavar; Shivakumar B Madagi
Journal:  Indian J Sex Transm Dis AIDS       Date:  2021-07-27

8.  An epidemiological survey of Mycoplasma hominis and Ureaplasma urealyticum in gynaecological outpatients, Rome, Italy.

Authors:  R Verteramo; A Patella; E Calzolari; N Recine; V Marcone; J Osborn; F Chiarini; A M Degener
Journal:  Epidemiol Infect       Date:  2013-02-28       Impact factor: 4.434

Review 9.  Prevalence of Urogenital Mycoplasmas in Iran and Their Effects on Fertility Potential: A Systematic Review and Meta-Analysis.

Authors:  Mohammad Hossein Ahmadi; Akbar Mirsalehian; Abbas Bahador
Journal:  Iran J Public Health       Date:  2016-04       Impact factor: 1.429

10.  Phylogenetics of Mycoplasma hominis clinical strains associated with gynecological infections or infertility as disclosed by an expanded multilocus sequence typing scheme.

Authors:  Safa Boujemaa; Amina Ben Allaya; Béhija Mlik; Helmi Mardassi; Boutheina Ben Abdelmoumen Mardassi
Journal:  Sci Rep       Date:  2018-10-05       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.